<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01053364</url>
  </required_header>
  <id_info>
    <org_study_id>NL-PROW-01</org_study_id>
    <nct_id>NCT01053364</nct_id>
  </id_info>
  <brief_title>Feasibility Study of NL-Prow Interspinous Spacer to Treat Lumbar Spinal Stenosis</brief_title>
  <official_title>Feasibility Study of NL-Prow Interspinous Spacer Device and Procedure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Non-Linear Technologies</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Non-Linear Technologies</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the clinical safety and feasibility of the NL-Prow™&#xD;
      Interspinous Spacer implant and insertion procedure in the treatment of lumbar spinal&#xD;
      stenosis&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">July 2011</completion_date>
  <primary_completion_date type="Anticipated">July 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accurate placement of the interspinous spacer confirmed by fluoroscopy</measure>
    <time_frame>Procedure completion</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement in leg and or back pain and in walking capability compared to baseline</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any device and or procedure related adverse events or complications</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Lumbar Spinal Stenosis</condition>
  <arm_group>
    <arm_group_label>Implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NL-Prow interspinous spacer implant</intervention_name>
    <description>Interspinous spacer implant</description>
    <arm_group_label>Implant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men and women ≥50 years of age.&#xD;
&#xD;
          -  Symptoms of leg/buttock/groin pain, with or without back pain, that are exacerbated by&#xD;
             lumbar extension and relieved in flexion.&#xD;
&#xD;
          -  Diagnosis of neurogenic intermittent claudication (NIC) (defined as a feeling of&#xD;
             paresthesia and/or discomfort and/or pain and/or weakness in the leg(s) during walking&#xD;
             or standing) secondary to lumbar spinal canal stenosis at 1-2 lumbar levels (between&#xD;
             L1 and L5), confirmed by dynamic X-Ray (showing sagital instability or rocking), and&#xD;
             CT and/or MRI (showing central spinal canal narrowing and/or foraminal narrowing).&#xD;
&#xD;
          -  Has completed at least 6 months of conservative therapy, which may include but is not&#xD;
             limited to, epidural steroid injections, oral steroids, NSAIDS, analgesics, physical&#xD;
             therapy, spinal manipulation, bracing.&#xD;
&#xD;
          -  Appropriate candidate for lumbar surgical treatment using posterior approach.&#xD;
&#xD;
          -  Subject can walk independently 15 meters or more.&#xD;
&#xD;
          -  Subject is able to understand the risks and benefits of participating in the study.&#xD;
&#xD;
          -  Subject understands and has signed the study informed consent form.&#xD;
&#xD;
          -  Subject is physically and mentally willing and able to comply with the requirements of&#xD;
             the study procedure and scheduled follow-up visits and testing.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe symptomatic lumbar spinal stenosis at ≥2 level, requiring surgical&#xD;
             intervention.&#xD;
&#xD;
          -  Prior lumbar spine surgery at any level.&#xD;
&#xD;
          -  Unremitting pain in any spinal position or axial back pain only without&#xD;
             leg/buttock/groin pain.&#xD;
&#xD;
          -  Evidence that subject's symptoms are due to vascular claudication OR has significant&#xD;
             peripheral vascular disease.&#xD;
&#xD;
          -  Significant instability of the lumbar spine at any level OR defined as translation of&#xD;
             more than 3mm or 10 degrees of angular motion between flexion and extension on upright&#xD;
             lateral radiographs.&#xD;
&#xD;
          -  Subject has an ankylosed segment at the affected level.&#xD;
&#xD;
          -  Significant scoliosis, defined as Cobb angle &gt;25°.&#xD;
&#xD;
          -  Cauda equina syndrome.&#xD;
&#xD;
          -  Fixed motor deficit or known peripheral neuropathy demonstrated clinically.&#xD;
&#xD;
          -  Subject has degenerative neurologic disease.&#xD;
&#xD;
          -  Subject has any mass lesions.&#xD;
&#xD;
          -  Any evidence of spinal or systemic infection.&#xD;
&#xD;
          -  Subject has a history of spinous process fracture or pars interarticularis fractures&#xD;
             or pathologic fractures of the vertebrae or multiple fractures of the vertebrae and/or&#xD;
             hips&#xD;
&#xD;
          -  Subject has history or radiographic evidence of 1 or more osteoporotic fractures in&#xD;
             the spine.&#xD;
&#xD;
          -  Subject has severe osteoporosis of the spine, defined as bone mineral density (BMD) in&#xD;
             the spine more than 2.5 SD below the mean of adult normals.&#xD;
&#xD;
          -  Subject is paraparetic.&#xD;
&#xD;
          -  Subject has a bleeding disorder.&#xD;
&#xD;
          -  Active systemic disease such as HIV, hepatitis, etc.&#xD;
&#xD;
          -  Subject is immunologically suppressed, or has received or is receiving 7.5 milligrams&#xD;
             prednisone (or equivalent) daily for more than six months immediately prior to&#xD;
             enrollment.&#xD;
&#xD;
          -  Extreme morbid obesity, defined as BMI &gt;35 kg/m2.&#xD;
&#xD;
          -  Diagnosis of lumbar spinal stenosis which requires a direct neural decompression or&#xD;
             surgical intervention other than those required to implant the experimental device.&#xD;
&#xD;
          -  Subject is not able to undergo MRI or tolerate closed MRI scan.&#xD;
&#xD;
          -  Known or suspected history of alcohol and/or drug abuse.&#xD;
&#xD;
          -  Life expectancy less than one year.&#xD;
&#xD;
          -  Active rheumatoid arthritis.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zdenek Novak, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Anne's University Hospital Brno, Czech Republic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Neurosurgery department, St. Anne's University Hospital</name>
      <address>
        <city>Brno</city>
        <zip>656 91</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czech Republic</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <study_first_submitted>January 19, 2010</study_first_submitted>
  <study_first_submitted_qc>January 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2010</study_first_posted>
  <last_update_submitted>January 4, 2011</last_update_submitted>
  <last_update_submitted_qc>January 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 5, 2011</last_update_posted>
  <responsible_party>
    <name_title>Lilach Eyal / Clinical Manager</name_title>
    <organization>Non-Linear Technologies</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Stenosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

